Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AME Study of [14C]-Rucaparib in Advanced Solid Tumors
NCT02986100Phase 1Completed
- Sponsor
- pharma&
- Start
- Nov 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of rucaparib in solid tumor, sponsored by pharma&. Primary endpoints: Time to Maximum Plasma Concentration, Maximum Plasma Concentration and 7 more. Started Nov 2016; status: completed.
02
Drugs
rucaparib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02986100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02986100.